Immunology, Immune system, Cancer research, Immunotherapy and T cell are his primary areas of study. His Immunology research focuses on Acquired immune system, IL-2 receptor, Antibody, Immunity and Innate lymphoid cell. The study incorporates disciplines such as Quorum sensing, Hepatitis B, Listeria monocytogenes and Molecular biology in addition to Immune system.
His biological study spans a wide range of topics, including Cancer cell, Cancer, Stimulator of interferon genes, Blockade and Antigen presentation. The various areas that Yang Xin Fu examines in his Immunotherapy study include Tumor microenvironment, Dendritic cell, Macrophage and Tumor necrosis factor alpha. His T cell research is multidisciplinary, incorporating perspectives in Immunoglobulin class switching, Cytotoxic T cell, Receptor and Cell biology.
Yang Xin Fu focuses on Immunology, Cancer research, Immune system, Cell biology and T cell. Immunology is represented through his Lymphotoxin, Immunotherapy, Lymphotoxin beta receptor, Antigen and Tumor necrosis factor alpha research. His Immunotherapy study integrates concerns from other disciplines, such as Dendritic cell and Radiation therapy.
In his study, CD8 is inextricably linked to Cytotoxic T cell, which falls within the broad field of Cancer research. His research ties Antibody and Immune system together. Yang Xin Fu works mostly in the field of Cell biology, limiting it down to topics relating to Follicular dendritic cells and, in certain cases, Molecular biology, as a part of the same area of interest.
His primary areas of study are Cancer research, Immune system, Immunology, Immunotherapy and Tumor microenvironment. Yang Xin Fu interconnects Cancer, T cell, Blockade, Cancer immunotherapy and Cytotoxic T cell in the investigation of issues within Cancer research. His study ties his expertise on Cell biology together with the subject of Immune system.
His Immunology research integrates issues from Receptor and Downregulation and upregulation. His work in Immunotherapy addresses issues such as Dendritic cell, which are connected to fields such as CTL*. His research integrates issues of Chimeric antigen receptor, Metastasis and Tumor antigen in his study of Tumor microenvironment.
Yang Xin Fu spends much of his time researching Cancer research, Immunotherapy, Immunology, Immune system and Tumor microenvironment. His study in Cancer research is interdisciplinary in nature, drawing from both Immune checkpoint, Blockade, T cell, PD-L1 and Radiation therapy. His Immunotherapy research focuses on Dendritic cell and how it connects with CTL*.
His studies in Immunology integrate themes in fields like Downregulation and upregulation and Cell biology. In his study, which falls under the umbrella issue of Immune system, Oncology is strongly linked to Internal medicine. His Tumor microenvironment research includes themes of Paracrine signalling, Lymphatic system, Neuron and Glioma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski;Hans Schreiber;Yang Xin Fu.
Nature Immunology (2013)
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng;Hua Liang;Byron Burnette;Michael Beckett.
Journal of Clinical Investigation (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng;Hua Liang;Meng Xu;Xuanming Yang.
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Youjin Lee;Sogyong L. Auh;Yugang Wang;Byron Burnette.
Development and maturation of secondary lymphoid tissues.
Yang Xin Fu;David D. Chaplin.
Annual Review of Immunology (1999)
Commensal bacteria protect against food allergen sensitization
Andrew T Stefka;Taylor Feehley;Prabhanshu Tripathi;Ju Qiu.
Proceedings of the National Academy of Sciences of the United States of America (2014)
The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.
Ju Qiu;Jennifer J. Heller;Xiaohuan Guo;Zong Ming E. Chen.
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity
Byron C. Burnette;Hua Liang;Youjin Lee;Lukasz Chlewicki.
Cancer Research (2011)
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum;Hua Liang;Liufu Deng;Yang Xin Fu.
Nature Reviews Clinical Oncology (2017)
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
Dongping Xu;Junliang Fu;Lei Jin;Hui Zhang.
Journal of Immunology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: